Rossari Biotech Limited
Rossari Biotech board approved a final dividend of Re. 0.50 per equity share (25%) for FY26. The record date and General Meeting date will be announced in due course.
Apr 28 2026 21:04:00
Rossari Biotech Limited
Rossari Biotech: Ms. Aparna Sharma's tenure as Non-Executive Independent Director concluded on April 28, 2026. The change is effective April 28, 2026, due to completion of her term.
Apr 28 2026 21:04:00
Rossari Biotech Limited
Rossari Biotech announced the availability of its Q4 FY26 earnings conference call audio recording. The call, held on April 28, 2026, is accessible on the company's website for investor review.
Apr 28 2026 20:04:00
Rossari Biotech Limited
Rossari Biotech announced that Ms. Aparna Sharma's tenure as an Independent Director concluded on April 28, 2026. The board expressed appreciation for her contributions during her service.
Apr 28 2026 20:04:00
Rossari Biotech Limited
Rossari Biotech reported Q4 FY26 revenue of ₹684.9 cr, up 18.2% YoY, and net profit of ₹46.0 cr, up 33.7% YoY. For FY26, revenue increased 15.2% to ₹2,396.4 cr, and net profit rose 9.4% to ₹149.2 cr. The board also recommended a dividend of Re. 0.50 per share.
Apr 28 2026 14:04:00
Rossari Biotech Limited
Rossari Biotech's Q4 FY26 cons. revenue increased by 18% YoY to ₹684.9 cr, and PAT grew 34% YoY to ₹46.0 cr. The company also commissioned an additional 15,000 MTPA ethoxylation capacity at Dahej, reaching a total of 66,000 MTPA.
Apr 28 2026 13:04:00
Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Rossari Biotech's Board has recommended a dividend of Re. 0.50 per share for the financial year 2025-26. This recommendation will be subject to shareholder approval at the upcoming Annual General Meeting.
Apr 28 2026 13:04:00
Rossari Biotech Limited
Rossari Biotech board approved a final dividend of Re. 0.50 per equity share (25%) for FY26. The record date and General Meeting date will be announced in due course.
Apr 27 2026 20:04:00
Rossari Biotech Limited
Rossari Biotech's board approved the appointment of Mr. Udeypaul Singh Gill as a Non-Executive Independent Director, effective April 28, 2026. He will serve a 36-month term, bringing over four decades of diverse industry experience.
Apr 27 2026 20:04:00
Rossari Biotech Limited
Rossari Biotech's board approved Q4 FY26 cons. results, with net profit rising 33.45% YoY to ₹45.97 crores and revenue at ₹684.86 crores. The company also declared a final dividend of ₹0.50 per share for FY26, appointed a new Independent Director, and established a new R&D facility in Navi Mumbai.
Apr 27 2026 18:04:00
Read More